Evidence map›Paper›PMID 36617460›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2023

Prevalence of post-COVID symptoms of obsessive-compulsive disorder in Saudi Arabia.

Mohammed A Alblowi, Waleed M Alkhammash, Thamer M Alzahrani, Mohammed H Hakeem, Saeed A Alsarar, Abdulhadi A Alqahtani, Abdulrahman M Almutairi, Turki H Al Binhar

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mohammed A AlblowiFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Waleed M AlkhammashFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Thamer M AlzahraniFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Mohammed H HakeemFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Saeed A AlsararFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Abdulhadi A AlqahtaniFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Abdulrahman M AlmutairiFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
Turki H Al BinharFrom the Department of Psychiatry (Alblowi), King Saud University Medical City, King Saud University, from the college of Medicine (Alzahrani, Hakeem, Alsarar, Alqahtani, Almutairi, Al Binhar), King Saud University, Riyadh, from the Department of Psychiatry (Alkhammash), Erada and Mental health complex, Ministry of Health, Taif, Kingdom of Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the prevalence of Obsessive-Compulsive Disorder (OCD) symptoms in patients who have survived COVID-19.

methodsThe study used an observational cross-sectional design between July and October 2021. The target population was adult patients who had confirmed COVID-19 infection prior to joining the study, OCD symptoms were assessed using the Arabic OCD scale created by Abohendy and colleagues, which included 83 questions covering 12 different domains and was administired online.

resultsA total of 356 patients were included in the analysis. Approximately 9.0% and 1.7% of the patients had a history of psychiatric disease and OCD diagnosis (respectively). The total symptom score was 32.8%. The most frequently reported domains were rumination of ideas (55.5%), re-checking compulsions (37.0%), and slowness (34.0%), while the least frequently reported domains included obsessive impulses (26.3%), obsessive images (26.5%), and religious compulsions (26.8%). Unlike other domains, the purity and cleanliness compulsions scores were significantly higher than the scale reference population. A higher total symptom score was observed in psychiatric patients (

conclusionOverall, OCD symptoms, including cleanliness and fear of disease obsessions, tend to be higher in psychiatric and OCD patients, these findings are valuable for future studies.

Indexed as

COVID-19Obsessive-Compulsive DisorderAdultCross-Sectional StudiesHumansPrevalencePsychiatric Status Rating ScalesSaudi Arabia

Identifiers

PMID36617460
PMCPMC9987626
OpenAlexW4313729193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.